DATE: 2010-03-10

NPR, 'Shots'		Wall Street Journal		Economic Times, Indiatimes		Forbes
Protesters, Including 'Vampire Squid,' Picket Health Insurers' Confab By Julie Rovner		Push to Cure Rare Diseases By Amy Dockser Marcus		GSK to lower prices to woo India mkt By Khomba Singh, Arun Kumar		What You Need To Know About Fish Oil By Matthew Herper

DATE: 2010-03-09

Financial Times		Forbes		Wall Street Journal		New York Times
Regulator finds ethics breach by AstraZeneca By Andrew Jack		Yet More Drugs Fail In Trials By Rebecca Ruiz		Test to Help Determine If Ovarian Masses Are Cancer By Laura Johannes		Infection Defense May Spur Alzheimer’s By Gina Kolata

DATE: 2010-03-08

Economic Times, Indiatimes		Fortune		Fox News		NPR
Standing guard: NPPA asked to monitor prices of antibiotics By Khomba Singh		World's Most Admired Companies By correspondents		'Trust' Gap Between House, Senate Dems Hurting Health Care Push By foxnews.com		Scientists Still Hopeful About Gene Therapy's Promise By Joe Palca

DATE: 2010-03-05

Business Week		New York Times		Times of London		BBC
Lessons of a $618,616 Death By Amanda Bennett, Charles Babcock		The Doctor’s Failure to Cut Costs By Pauline W. Chen, M.D.		New regime to keep vital medicines in the country By Catherine Boyle		Human gut microbes hold 'second genome' By Doreen Walton

DATE: 2010-03-04

Wall Street Journal		New York Times		Financial Times		NPR
FDA Criminal Division to Increase Prosecutions By Alicia Mundy		Hopes for Alzheimer’s Drug Are Dashed By Andrew Pollack		Pfizer / Ratiopharm By Lex team		Why Pay For Health Insurance When You Can Steal It? By Jennifer Moore

DATE: 2010-03-03

NPR		The Guardian		Economic Times, Indiatimes		Wall Street Journal
Obama Extends Slender Olive Branch To GOP On Overhaul By Julie Rovner		AstraZeneca to close UK research centre with 1,200 job losses By Nick Mathiason		Ranbaxy loses out on FDA delay By Khomba Singh		Bristol-Myers Names New CEO By Jonathan D. Rockoff, Peter Loftus

DATE: 2010-03-02

NPR		Financial Times, Opinion		Wall Street Journal		Huffington Post
Reconciliation Won't Be Smooth Ride For Health Bill By Liz Halloran		Merck / Millipore By Lex Team		Beep! It's Your Medicine Nagging You By Anna Wilde Mathews		Do PR Firms Makes Sense Anymore? By Grant Cardone

DATE: 2010-03-01

Financial Times		Economic Times, Indiatimes		Wall Street Journal		Forbes
Merck to buy Millipore in $7.2bn deal By Lina Saigol, Helen Thomas		No interim stay on Cipla’s Nexavar clone By Khomba Singh		Bayer Posts 44% Rise in Earnings By Allison Connolly		The Mathematics Of Cancer By Robert Langreth

DATE: 2010-02-26

New York Times		Business Week		Economic Times, Indiatimes		Times of London
President Urges Focus on Common Ground By Sheryl Gay Stolberg, Robert Pear		Eli Lilly's Drug Assembly Line By Arlene Weintraub, Meg Tirrell		Union Budget 2010: Drugmakers to benefit from budgetary measures By IST, ET Bureau		GSK chief nets 76% pay rise after one year By Catherine Boyle, Miles Costello

DATE: 2010-02-25

Wall Street Journal		New York Times		Forbes		Economic Times, Indiatimes
Trusting Other Patients' Drug Advice By Jonathan D. Rockoff		Health Executive Defends Premiums By Robert Pear		Drug Companies Disappoint Me Again By Dr. Harlan Krumholz		Polymed gets to sell IV device in Germany By Khomba Singh

DATE: 2010-02-24

New York Times		The Guardian		Financial Times		Wall Street Journal
Big Questions Still Linger on Eve of Health Care Meeting By David Leonhardt		AstraZeneca agrees to pay £505m to settle UK tax dispute By Richard Wachman		Pharma groups team up on cancer research By Andrew Jack		Teasing Vaccines From Tobacco By Gautam Naik

DATE: 2010-02-23

New York Times		Financial Times		The Guardian		Wall Street Journal, Health Blog
Obama’s Health Bill Plan Largely Follows Senate Version By Sheryl Gay Stolberg, David M. Herszenhorn		White House tilts at barrier to cheap drugs By Stephanie Kirchgaessner		Glaxo's handling of Avandia concerns damned by US Senate committee By Andrew Clark		Lander: Why Can’t Science and Economics Work Together? By Shirley S. Wang

ABOUT BETSY RAYMOND STEVENSON

Founder and Principal, RaymondStevenson Healthcare Communications (RSHC) >>>

ABOUT RSHC
Building Healthy Relationships

Expert and creative communications services for the pharmaceutical and biotechnology industries. >>>

• Strategic media relations
• Thought leader relations
• Integrated social media relations
• Media interview coaching
• Tactical support
• Issues management
• Global expertise
• Developing world expertise

PROFESSIONAL SOURCES